Firstcall's reserach report on FDCFDC (Foods, Drugs & Chemicals) formerly known as FairDeal Corporation, has been in the pharmaceutical business for more than seven decades now. FDC is a people oriented organization dedicated to innovate, manufacture and market high-quality healthcare products. FDC strives to explore, innovate and integrate solutions with modern technology, empowering talent and expanding healthcare horizons for a better quality of life to millions globally.Price to Book Value of the stock is expected to be at 3.70 x and 3.15 x for FY16E and FY17E respectively.We recommend ‘BUY’ in this particular scrip with a target price of Rs. 263.00 for Medium to Long term investment.For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
Read More
